Promoting the public’s understanding of regenerative medicine in society

EuroStemCell and Regenerative Medicine launch an online resource to engage and educate non-experts on the key issues surrounding regenerative medicine.

Go to the profile of Regenerative Medicine
Dec 05, 2017

EuroStemCell, in partnership with the Future Science Group MEDLINE-indexed journal Regenerative Medicine, have launched a digital platform which provides free-to-access summaries of hot-topic articles from leading international academics published in the journal’s recent two-part Special Focus Issue entitled, ‘Regenerative Medicine in Society: Interdisciplinary Perspectives’.  

Visit the resource

The fields of stem cell and regenerative medicine research offer great promise for the production of novel therapeutic techniques in order to enhance patient outcomes. Nevertheless, developments in regenerative medicine have sparked public controversy and there are still numerous social, ethical, regulatory, legal and economic issues that must be addressed. The Special Focus Issue provides an expansive collection of research and perspectives on these important topics.

The double issue was published in collaboration with the European Commission-funded EuroStemCell project through Guest Editors Jan Barfoot and Clare Blackburn (both MRC Centre for Regenerative Medicine, University of Edinburgh, UK), as well as Achim Rosemann (University of Warwick, UK).

Barfoot stated, “Through this collaboration, we have been able to realise this ambitious, global project, attracting leading international scholars and academics to contribute their insights regarding regenerative medicine in society.”

The recently launched digital platform accompanies the publication of the two-part Special Focus Issue and presents lay summaries of each article that are freely available to all, which provide key insights into a number of inter-disciplinary research projects from across the globe.

The ultimate aim of the digital gateway is to bridge the gap between researchers and individuals outside of academia. The concise and engaging summaries are targeted to a broader audience to allow maximum involvement.

"Our mission is to stimulate conversations in all sectors on the impact of regenerative medicine on society, so we are very pleased to make summaries of this work freely available,” explained Barfoot.

“This body of work provides a rare and in-depth insight into the big questions surrounding the future of the sector. Our hope is that policymakers, regulators, healthcare leaders, funders, patient support organisations and others will read, search and download these research summaries for deliberation with their colleagues.”

Adam Price-Evans, Managing Commissioning Editor of Regenerative Medicine stated, “I am delighted that, through partnership with EuroStemCell, we will be able to enhance the outreach of this important work to a wider audience and hopefully educate and spark debate amongst non-experts on important issues surrounding regenerative medicine. Transparency and understanding will continue to be vital going forward, so I hope that this project can contribute to this and assist in realizing the field’s great potential.”

The EuroStemCell digital gateway with all lay summaries can be accessed here:

View Parts I and II of the Special Focus Issue "Regenerative Medicine in Society: Interdisciplinary Perspectives" here:

Part I:

Part II:

Go to the profile of Regenerative Medicine

Regenerative Medicine

Journal, Future Science Group

Regenerative Medicine is an award-winning peer-reviewed journal, in print and web formats. The journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats. Among other indexing services Regenerative Medicine is listed by MEDLINE/Index Medicus, EMBASE/Excerpta Medica, Chemical Abstracts, Science Citation Index Expanded™ (SciSearch®), Emcare, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, Journal Citation Reports/Science Edition®, Scopus® with an Impact Factor of 2.786 (2014). Each issue contains expertly drafted Reviews, Original Research articles, Perspectives, Editorials, topical insight from international leaders in their field, and additional added-value content. The Senior Editor of the journal is Professor Chris Mason, University College London. You can find out more about Regenerative Medicine at our website (, where you can find the aims and scope of the journal and details of our international editorial board.

No comments yet.